-
Mashup Score: 0
Article InfoPublication HistoryAccepted: October 14, 2022Received in revised form: September 28, 2022Received: June 26, 2022Publication stageIn Press Journal Pre-ProofFootnotesThis research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. AZ received…
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0Angioedema Due to Acquired Deficiency of C1-Inhibitor: A Cohort Study in Spain and a Comparison With Other Series - 3 year(s) ago
Data on acquired angioedema due to C1-inhibitor deficiency (C1-INH-AAE) from 4 European countries (France, Italy, Germany, and Hungary) were recently published.
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! #Angioedema Due to #Acquired #Deficiency of #C1- #Inhibitor: A Cohort Study in Spain and a Comparison With Other Series https://t.co/YDgd34i7dp https://t.co/YUTxtufYN3
-
-
Mashup Score: 3Angioedema Due to Acquired Deficiency of C1-Inhibitor: a Cohort Study in Spain and a Comparison With Other series. - 3 year(s) ago
Data on acquired angioedema due to C1-inhibitor deficiency (C1-INH-AAE) from 4 European countries (France, Italy, Germany, and Hungary) were recently published.
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Press! #Angioedema Due to #Acquired #Deficiency of #C1- #Inhibitor: a Cohort Study in Spain and a Comparison With Other series. https://t.co/YDgd34i7dp
-
-
Mashup Score: 0
Acquired angioedema with C1-inhibitor deficiency (C1-Inh AAE) is a rare, life-threatening disease.1 Like the C1-Inh hereditary angioedema (C1-Inh HAE), it is characterized by transient recurrent subcutaneous and/or submucosal swelling episodes, which mainly affect the skin, gastrointestinal tract, and upper airways.1 However, contrary to the hereditary form, C1-Inh AAE has a late onset…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! Efficacy of #lanadelumab in acquired #angioedema with #C1- #inhibitor #deficiency https://t.co/vWIAUvC7dO https://t.co/2tZDCuMSjG
-
-
Mashup Score: 0
Acquired angioedema with C1-inhibitor deficiency (C1-Inh AAE) is a rare, life-threatening disease.1 Like the C1-Inh hereditary angioedema (C1-Inh HAE), it is characterized by transient recurrent subcutaneous and/or submucosal swelling episodes, which mainly affect the skin, gastrointestinal tract, and upper airways.1 However, contrary to the hereditary form, C1-Inh AAE has a late onset…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Press! Efficacy of #Lanadelumab in #acquired #angioedema with #C1- #inhibitor #deficiency https://t.co/vWIAUvC7dO
-
-
Mashup Score: 0COVID-19 affecting hereditary angioedema patients with and without C1 inhibitor deficiency - 4 year(s) ago
At the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, age more than 60 years, hypertension, and diabetes mellitus have been identified as the major risk factors for severe cases of coronavirus disease 2019 (COVID-19). The knowledge about COVID-19’s immunopathogenesis has been increasing rapidly. The pathogenicity of COVID-19 is not restricted to the…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue (Free)! #COVID- #19 affecting #hereditary #angioedema patients with and without #C1 #inhibitor #deficiency https://t.co/80ivOHf3Fw https://t.co/t5ZUZkZW2s
-
-
Mashup Score: 2COVID-19 AFFECTING HEREDITARY ANGIOEDEMA PATIENTS WITH AND WITHOUT C1 INHIBITOR DEFICIENCY - 4 year(s) ago
Article InfoPublication HistoryAccepted: November 20, 2020Received in revised form: November 18, 2020Received: August 29, 2020Publication stageIn Press Journal Pre-ProofFootnotesConflict of Interest: The authors have no conflicts of interest to declare regarding this manuscript.Funding Sources: This research received no…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Press (Free)! #COVID- #19 AFFECTING #HEREDITARY #ANGIOEDEMA PATIENTS WITH AND WITHOUT #C1 #INHIBITOR #DEFICIENCY https://t.co/80ivOHf3Fw
-
-
Mashup Score: 0
Plasma-derived C1-inhibitor (pdC1-INH) is a first-line therapy for hereditary angioedema (HAE) with C1-inhibitor deficiency (C1-INH-HAE) in pediatric patients.
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! Clinical Characteristics and Safety of #Plasma- #Derived #C1- #Inhibitor #Therapy in #Children and #Adolescents with #Hereditary #Angioedema—A Long-Term Survey https://t.co/Vf426Qt4TK https://t.co/n0ZUN5znUX
-
-
Mashup Score: 0Subcutaneous C1-Inhibitor Well-Tolerated, Effective in Hereditary Angioedema - Pulmonology Advisor - 5 year(s) ago
Older patients with hereditary angioedema who were treated with a subcutaneous injection of C1-INH had fewer attacks than baseline.
Source: Pulmonology AdvisorCategories: Latest Headlines, PulmonologyTweet-
#Subcutaneous #C1-inhibitor was found to be well-tolerated and effective in hereditary #angioedema #Pulmonology #PulmTwitter https://t.co/w7tsezPAAe
-
-
Mashup Score: 0Experience with Intravenous Plasma-Derived C1-Inhibitor in Pregnant Women with Hereditary Angioedema: A Systematic Literature Review - 5 year(s) ago
Consensus guidelines recommend plasma-derived C1 inhibitor (C1-INH) as first-line treatment in pregnant women with hereditary angioedema (HAE). We conducted a systematic review of the literature that describes experience with plasma-derived C1-INH during pregnancy. A literature search of PubMed was conducted in November 2018 using variants of “hereditary angioedema” and “pregnancy.” English…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! Experience with #Intravenous #Plasma- #Derived #C1- #Inhibitor in #Pregnant #Women with #Hereditary #Angioedema: A Systematic Literature Review https://t.co/9wXQdKp08D https://t.co/MYNEW2ZhEE
-
In Press! Efficacy of #Lanadelumab in #angioedema due to #acquired #C1 #inhibitor #deficiency https://t.co/7tKR0NUgWR